FdaApplication
NDA 022157
Identifiers
- fda_app_no: NDA022157
Properties
| Property | Value |
|---|---|
| applicant_name | CHATTEM INC DBA SANOFI CONSUMER HEALTHCARE |
| application_type | NDA |
| approval_date | 2008-01-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XYZAL | LEVOCETIRIZINE DIHYDROCHLORIDE | 2.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;ORAL |
1 product